1. Sutera S, Furchì OA, Pentenero M. Investigating tumor-infiltrating lymphocytes in the microenvironment of oral squamous cell carcinoma (OSCC) and oral potentially malignant disorders (OPMDs): Can they shift our perspective? A scoping review. J Clin Med. 2025;14(2):606.
https://doi.org/10.3390/jcm14020606
PMid:39860614 PMCid:PMC11766165

2. Chaturvedi A, Husain N, Misra S, Kumar V, Gupta S, Akhtar N, et al. Validation of the Brandwein Gensler risk model in patients of oral cavity squamous cell carcinoma in North India. Head Neck Pathol. 2020;14(3):616-622.
https://doi.org/10.1007/s12105-019-01082-6
PMid:31552620 PMCid:PMC7413965

3. Elseragy A, Bello IO, Wahab A, Coletta RD, Mäkitie AA, Leivo I, et al. Emerging histopathologic markers in early-stage oral tongue cancer: A systematic review and meta-analysis. Head Neck. 2022;44(6):1481-1491.
https://doi.org/10.1002/hed.27022
PMid:35229398 PMCid:PMC9545479

4. Almangush A, Salo T, Haglund C, Kowalski LP, Hagström J, Coletta RD, et al. Validation of a new histopathologic risk model in early oral tongue cancer: A combination of a modified worst pattern of invasion and a new tumor budding score. Am J Surg Pathol. 2025;49(10):1036-1041.
https://doi.org/10.1097/PAS.0000000000002433
PMid:40499008 PMCid:PMC12435260

5. Chaithra H, Geetha JP, Lokesh MR. The role of histologic risk assessment as a prognostic indicator in oral squamous cell carcinoma. J Popul Ther Clin Pharmacol. 2025;32(7):714-719.
https://doi.org/10.53555/pr7zx033

6. Kunhikoloth S, Bijjaragi S, Somanath A, Sah VP. Tumor-infiltrating lymphocytes as a prognostic parameter in oral squamous cell carcinoma. IP Arch Cytol Histopathol Res. 2024;9(2):81-86.
https://doi.org/10.18231/j.achr.2024.017

7. Raja Sekhar SVR, Pappala P, Bonu RC, Balli G. Prognostic role of histological scoring of oral squamous cell carcinoma. J Clin Diagn Res. 2022;16(5):EC32-EC36.
https://doi.org/10.7860/JCDR/2022/56672.16350

8. Rahman N, MacNeill M, Wallace W, Conn B. Reframing histological risk assessment of oral squamous cell carcinoma in the era of UICC 8th Edition TNM staging. Head Neck Pathol. 2021;15:202-211.
https://doi.org/10.1007/s12105-020-01201-8
PMid:32661668 PMCid:PMC8010015

9. Kakkar A, Thakur R, Roy D, Sood R, Sharma A, Malhotra RK, et al. Tumour-infiltrating lymphocyte subsets and their individual prognostic impact in oral squamous cell carcinoma. J Clin Pathol. 2024;77(12):822-828.
https://doi.org/10.1136/jcp-2023-208918
PMid:37699696

10. Xu B, Salama AM, Valero C, Yuan A, Khimraj A, Saliba M, et al. Histologic evaluation of host immune microenvironment and its prognostic significance in oral tongue squamous cell carcinoma: A comparative study on lymphocytic host response and tumor infiltrating lymphocytes. Pathol Res Pract. 2021;228:153473.
https://doi.org/10.1016/j.prp.2021.153473
PMid:34059347 PMCid:PMC9423079

11. Hendry S, Salgado R, Gevaert T, Russell PA, John T, Thapa B, et al. Assessing tumor infiltrating lymphocytes in solid tumors: A practical review for pathologists and proposal for a standardized method from the International Immuno-Oncology Biomarkers Working Group. Adv Anat Pathol. 2018;24(5):235-251.
https://doi.org/10.1097/PAP.0000000000000162
PMid:28777142 PMCid:PMC5564448

12. Sankala M, Rangwala HA. Prediction of early oral squamous cell carcinoma recurrence based on the histological risk score. Int J Pharm Res. 2023;15(11):1527-1532.

13. Marzouki HZ, Bukhari AF, Al-Ghamdi DA, Abdullah RM, Al-Hajeili M, Khayyat S, et al. Worst pattern of invasion and other histopathological features in oral cancer as determinants of prognosis and survival rate: A retrospective cohort analysis. Oncol Lett. 2023;25(2):75.
https://doi.org/10.3892/ol.2023.13661
PMid:36688107 PMCid:PMC9834764

14. Thakur R, Thakar A, Malhotra RA, Sharma A, Kakkar A. Tumor host interface in oral squamous cell carcinoma: Impact on nodal metastasis and prognosis. Eur Arch Otorhinolaryngol. 2021;278(12):5029-5039.
https://doi.org/10.1007/s00405-021-06853-y
https://doi.org/10.1007/s00405-021-06756-y
PMid:33743065

15. Dar MA, Sharma KK. Burden of cancer in India: GLOBOCAN 2018 estimates incidence, mortality, prevalence and future projections of cancer in India. J Emerg Technol Innov Res. 2019;6(6):505-514.

16. Almangush A, Mäkitie AA, Triantafyllou A, de Bree R, Strojan P, Rinaldo A, et al. Staging and grading of oral squamous cell carcinoma: An update. Oral Oncol. 2020;107:104799.
https://doi.org/10.1016/j.oraloncology.2020.104799
PMid:32446214

17. Akolkar S, Hande A, Gawande M, Patil S, Sonone A, Pakhale A. Protocol for assessment and correlation of Brandwein-Gensler criteria with P53 immunoexpression in oral squamous cell carcinoma: A retrospective study. F1000Res. 2024;12:1238.
https://doi.org/10.12688/f1000research.134509.1
https://doi.org/10.12688/f1000research.134509.2

18. Binmadi N, Alsharif M, Almazrooa S, Aljohani S, Akeel S, Osailan S, et al. Perineural invasion is a significant prognostic factor in oral squamous cell carcinoma: A systematic review and meta-analysis. Diagnostics (Basel). 2023;13(21):3339.
https://doi.org/10.3390/diagnostics13213339
PMid:37958235 PMCid:PMC10649820

19. Xu Q, Wang C, Yuan X, Feng Z, Han Z. Prognostic value of tumor-infiltrating lymphocytes for patients with head and neck squamous cell carcinoma. Transl Oncol. 2017;10(1):10-16.
https://doi.org/10.1016/j.tranon.2016.10.005
PMid:27888708 PMCid:PMC5123038

20. Schneider CA, Rasband WS, Eliceiri KW. NIH Image to ImageJ: 25 years of image analysis. Nat Methods. 2012;9(7):671-675.
https://doi.org/10.1038/nmeth.2089
PMid:22930834 PMCid:PMC5554542

21. Khan SM, Prakash N, Mokashi RR, Gajdhar SK, Sadhwani V, Manva MZ. Histopathological grades of oral squamous cell carcinoma as a prognostic indicator: Hospital-based study. Int J Med Res Health Sci. 2022;11(3):17-22.

22. Rahman N, Conn B. Evaluation of histopathological risk model in a cohort of oral squamous cell carcinoma patients treated with accompanying neck dissection. Head Neck Pathol. 2021;15:1156-1161.
https://doi.org/10.1007/s12105-021-01326-4
PMid:33886072 PMCid:PMC8633176

23. Wongpattaraworakul W, Choi A, Buchakjian MR, Lanzel EA, Kd AR, Simons AL. Prognostic role of tumor-infiltrating lymphocytes in oral squamous cell carcinoma. BMC Cancer. 2024;24(1):766.
https://doi.org/10.1186/s12885-024-12539-5
PMid:38926643 PMCid:PMC11201865

24. Herman M, Michalek J, Pink R, Kopecka K, Zapletalova J, Hotarkova S, et al. Prognostic impact of immune phenotype in oral squamous cell carcinoma. Oral Oncol. 2025;168:107568.
https://doi.org/10.1016/j.oraloncology.2025.107568
PMid:40737992

25. Almangush A, Jouhi L, Atula T, Haglund C, Mäkitie AA, Hagström J, et al. Tumour-infiltrating lymphocytes in oropharyngeal cancer: A validation study according to the criteria of the International Immuno-Oncology Biomarker Working Group. Br J Cancer. 2022;126(11):1589-1594.
https://doi.org/10.1038/s41416-022-01708-7
PMid:35043007 PMCid:PMC9130301

26. Dolens EDS, Dourado MR, Almangush A, Salo TA, Gurgel Rocha CA, da Silva SD, et al. The impact of histopathological features on the prognosis of oral squamous cell carcinoma: A comprehensive review and meta-analysis. Front Oncol. 2021;11:784924.
https://doi.org/10.3389/fonc.2021.784924
PMid:34858861 PMCid:PMC8631280

27. Majumdar B, Patil S, Sarode SC, Sarode GS, Rao RS. Clinico-pathological prognosticators in oral squamous cell carcinoma: An update. Transl Res Oral Oncol. 2017;2:1-14.
https://doi.org/10.1177/2057178X17738912

28. Sethi S, Ohri S, Aggarwal P, Grewal H. Histopathological factors in oral squamous cell carcinoma: Should a clinician look beyond clinical staging? J Oral Maxillofac Surg. 2021;79(8):1694-1705.
https://doi.org/10.1016/j.joms.2021.02.014
PMid:33744240

29. Iseki Y, Shibutani M, Maeda K, Nagahara H, Fukuoka T, Matsutani S, et al. A new method for evaluating tumor-infiltrating lymphocytes in colorectal cancer using hematoxylin and eosin-stained tumor sections. PLoS One. 2018;13(4):e0192744.
https://doi.org/10.1371/journal.pone.0192744
PMid:29698402 PMCid:PMC5919485

30. Morais E, Almangush A, Salo T, Silva S, Kujan O, Coletta RD. Emerging histopathological parameters in the prognosis of oral squamous cell carcinomas. Histol Histopathol. 2024;39:1-12.

31. Ahuja S, Khan AA, Zaheer S, Ranga S. Tumor-infiltrating lymphocytes in oral cavity squamous cell carcinoma and its association with clinicopathological parameters. Pathol Res Pract. 2023;251:154882.
https://doi.org/10.1016/j.prp.2023.154882
PMid:37898039

32. Książek M, Lewandowski B, Brodowski R, Pakla P, Kawalec-Książek M, Fudali L, et al. The prognostic significance of tumour infiltrating lymphocytes in oral squamous cell carcinoma. Pol J Pathol. 2019;70(4):277-285.
https://doi.org/10.5114/pjp.2019.93130
PMid:32146797

33. Heikkinen I, Bello IO, Wahab A, Hagström J, Haglund C, Coletta RD, et al. Assessment of tumor-infiltrating lymphocytes predicts the behavior of early-stage oral tongue cancer. Am J Surg Pathol. 2019;43(10):1392-1396.
https://doi.org/10.1097/PAS.0000000000001323
PMid:31290758

34. Navarro Cuéllar I, Espías Alonso S, Alijo Serrano F, Herrera Herrera I, Zamorano León JJ, Del Castillo Pardo de Vera JL, et al. Depth of invasion: Influence of the latest TNM classification on the prognosis of clinical early stages of oral tongue squamous cell carcinoma and its association with other histological risk factors. Cancers (Basel). 2023;15(19):4882.
https://doi.org/10.3390/cancers15194882
PMid:37835576 PMCid:PMC10571553

35. Fonseca D, Khemani R, Pasam MK, Tagore R, Rao BV, Kodandapani S, et al. Histological risk score and its role in predicting recurrence in early-stage oral squamous cell carcinomas. Indian J Pathol Microbiol. 2023;66(3):444-448.
https://doi.org/10.4103/ijpm.ijpm_514_21
PMid:37530322

36. Verma R, Singh A, Chowdhury N, Joshi PP, Durgapal P, Rao S, et al. Evaluation of histomorphological parameters to predict occult nodal metastasis in early-stage oral squamous cell carcinoma. Turk Patoloji Derg. 2022;38(3):227-234.
https://doi.org/10.5146/tjpath.2021.01566
PMid:34978064 PMCid:PMC10508408

37. Mohamed S, Jawad H, Sullivan RO, Callanan D, Sheahan P, Feeley L. Significance of worst pattern of invasion-5 in early-stage oral cavity squamous cell carcinoma. Head Neck Pathol. 2023;17(3):679-687.
https://doi.org/10.1007/s12105-023-01571-9
PMid:37486537 PMCid:PMC10513981